Vertex VERX 深 沪
等待开盘 10-10 09:30:00 美东时间
12.95
+0.180
+1.41%
华盛通- 最 高12.965
- 今 开12.77
- 成交量 96.13万股
- 最 低 12.655
- 昨 收 12.77
- 总市值 210.07万
- 52周最高 26.54
- 市盈率 静 291.67
- 换手率 0.59%
- 52周最低 10.21
- 委 比 -99.57%
- 总股本 0.00亿
- 历史最高 60.71
- 量 比 0.76
- 振 幅 2.43%
- 历史最低 9.44
- 每 手 1
- 风险率 4.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vertex Presents Study Reporting ALYFTREK Data Shows Pancreatic Function Recovery In Some Children Ages 2–5 With Cystic Fibrosis
Vertex Presents Study Reporting ALYFTREK Data Shows Pancreatic Function Recovery In Some Children Ages 2–5 With Cystic Fibrosis
今天 01:17
伊赛亚斯飓风扰乱墨西哥湾美国原油生产，对炼油厂构成威胁
核心要点 伊赛亚斯飓风正在扰乱美国墨西哥湾原油生产。 截至周四，石油企业关停约 130 万桶 / 日原油产能，约占墨西哥湾美国原油总产量的 63%。 飓风...
10-09 21:48
交易拥挤！美银警告：“买AI、卖消费”赚超额收益越来越难
美银证券最新发布的《主动管理人持仓更新》报告指出，主动基金持仓已充分反映“消费转向资本开支”主题，通过买入AI资本开支受益者、卖出白领消费主题来赚取超额收益正变...
10-05 19:51
Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors
Vertex Inc. appoints Debanjan Saha to its Board of Directors, effective October 7, 2026. Saha brings over two decades of experience in building and scaling multi-billion dollar AI, data, and cloud businesses. He currently serves as CEO of DataRobot and has held leadership roles at Google Cloud and Amazon Web Services. His expertise in AI and cloud transitions will support Vertex's AI-first transformation in indirect tax and compliance. Saha's add...
10-01 12:00
Alphabet To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. UBS raised the price target for Vertex Pharmaceuticals Inc (NASDAQ:VRTX) from $585 to $615. UBS analyst Michae...
09-29 02:46
Vertex Revamps Leadership at Key Subsidiary to Tighten Group Governance
Vertex Corp. ( ($JP:5290) ) has provided an update. Vertex Corporation has anno...
09-25 16:22
Vertex Minerals Sets October General Meeting for Shareholders
Vertex Minerals Ltd. ( ($AU:VTX) ) has issued an update. Vertex Minerals Ltd. i...
09-25 15:37
Vertex Touts Encouraging Data From 'Underappreciated' Kidney Drug
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Tuesday reported data from its Phase 2b AMPLIFIED trial evaluating inaxaplin in individuals with APOL1-mediated kidney disease (AMKD). The study tested a daily 45 mg dose alongside optimized standard care across two distinct patient groups with ei...
09-23 01:55
Vertex reports positive mid-stage results of inaxaplin for kidney disease
Vertex Pharmaceuticals (VRTX) said that data from a phase 2b trial found that the experimental drug inaxaplin led to a significant decline in proteinuria in individuals with APOL1-mediated kidney dise...
09-22 23:24
2026绿智未来可持续发展全球挑战赛正式启幕
来源：投中网 为深入推进国际绿色经济标杆城市建设，汇集国际资源，打造高能级绿色发展标志性活动，2026“绿智未来”可持续发展全球挑战赛（Green F...
09-19 11:16
